CR9053A - Uso de 2-fenil-1,2-etanodiol-(id) carbamatos para tratar epileptogenesis y epilepsia - Google Patents

Uso de 2-fenil-1,2-etanodiol-(id) carbamatos para tratar epileptogenesis y epilepsia

Info

Publication number
CR9053A
CR9053A CR9053A CR9053A CR9053A CR 9053 A CR9053 A CR 9053A CR 9053 A CR9053 A CR 9053A CR 9053 A CR9053 A CR 9053A CR 9053 A CR9053 A CR 9053A
Authority
CR
Costa Rica
Prior art keywords
phenyl
group
epilepsy
alkyl
ethanodiol
Prior art date
Application number
CR9053A
Other languages
English (en)
Inventor
Yong Moon Choi
Robert Gordon
Gerald P Novak
Carlos R Plata-Salaman
Roy E Twyman
H Steve White
Boyu Zhao
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CR9053A publication Critical patent/CR9053A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Esta invencion se refiere a metodos para prevenir, tratar, revertir, inhibir o detener la epilepsia y epiletogenesis en un sujeto, que comprende administrar al sujeto en necesidad del mismo una cantidad terapeuticamente efectiva de un compuesto seleccionado del grupo que consiste en la formula (I) y formula (II), o un sal o ester farmaceuticamente aceptable del mismo.
CR9053A 2004-09-16 2007-04-13 Uso de 2-fenil-1,2-etanodiol-(id) carbamatos para tratar epileptogenesis y epilepsia CR9053A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61027604P 2004-09-16 2004-09-16
US69862505P 2005-07-12 2005-07-12
US70724205P 2005-08-11 2005-08-11

Publications (1)

Publication Number Publication Date
CR9053A true CR9053A (es) 2009-10-30

Family

ID=36087909

Family Applications (1)

Application Number Title Priority Date Filing Date
CR9053A CR9053A (es) 2004-09-16 2007-04-13 Uso de 2-fenil-1,2-etanodiol-(id) carbamatos para tratar epileptogenesis y epilepsia

Country Status (23)

Country Link
US (2) US20060194873A1 (es)
JP (1) JP2008513466A (es)
KR (1) KR20070057939A (es)
CN (1) CN101056629B (es)
AT (1) ATE464044T1 (es)
AU (1) AU2005287174B2 (es)
BR (1) BRPI0515374A (es)
CA (1) CA2580640A1 (es)
CO (1) CO6382111A2 (es)
CR (1) CR9053A (es)
DE (1) DE602005020667D1 (es)
DK (1) DK1809273T3 (es)
EA (1) EA200700642A1 (es)
ES (1) ES2342185T3 (es)
HK (1) HK1105583A1 (es)
HR (1) HRP20100304T1 (es)
IL (1) IL181910A0 (es)
MX (1) MX2007003278A (es)
NO (1) NO20071921L (es)
NZ (1) NZ553813A (es)
PT (1) PT1809273E (es)
RS (1) RS51269B (es)
WO (1) WO2006033947A2 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ517407A (en) * 1999-08-10 2003-10-31 Uab Research Foundation Use of GABA agonists for treatment of spastic disorders, convulsions, and epilepsy
AU2005295787A1 (en) * 2004-10-15 2006-04-27 Janssen Pharmaceutica, N.V. Carbamate compounds for use in treating neurodegenerative disorders
PE20070325A1 (es) * 2005-06-29 2007-05-12 Alza Corp Formas de dosificacion oral que comprenden compuestos derivados de carbamato
US20070021500A1 (en) * 2005-07-12 2007-01-25 Twyman Roy E Methods for neuroprotection
US20070043120A1 (en) * 2005-08-18 2007-02-22 Bettina Beyreuther Therapeutic combination for painful medical conditions
JP5443981B2 (ja) 2006-06-15 2014-03-19 ウーツェーベー ファルマ ゲーエムベーハー 相乗的抗痙攣効果を有する医薬組成物
EA200970355A1 (ru) * 2006-10-06 2009-12-30 Янссен Фармацевтика Нв Новый кристалл (s)-(+)-2-(2-хлорфенил)-2-гидроксиэтилкарбамата
MX2009004798A (es) * 2006-10-31 2009-08-12 Janssen Pharmaceutica Nv Tratamiento de los trastornos generalizados del desarrollo.
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
EP2797881B1 (en) * 2011-12-27 2018-11-14 Bio-Pharm Solutions Co., Ltd. Phenyl alkyl carbamate derivative compound and pharmaceutical composition containing the same
KR101717872B1 (ko) * 2013-03-12 2017-03-17 (주)바이오팜솔루션즈 소아 간질 및 간질-관련 증후군의 예방 또는 치료용 페닐카바메이트 화합물
EP2970109A4 (en) * 2013-03-12 2017-01-18 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for neuroprotection comprising the same
JP6807941B2 (ja) * 2016-02-29 2021-01-06 バイオ−ファーム ソリューションズ カンパニー リミテッド スルファメート誘導体化合物、その製造方法および用途
CN106053510A (zh) * 2016-05-16 2016-10-26 山东省分析测试中心 一种基于氢核磁共振快速测定普瑞巴林原料药纯度的方法
KR102421006B1 (ko) * 2016-05-19 2022-07-14 에스케이바이오팜 주식회사 두통의 예방학적 치료를 위한 카바메이트 화합물의 용도

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) * 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
US20010034365A1 (en) * 1996-01-16 2001-10-25 Choi Yong Moon Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
WO1997045160A1 (en) * 1996-05-31 1997-12-04 Southern Illinois University Methods of modulating aspects of brain neural plasticity by vagus nerve stimulation
PT1156798E (pt) * 1999-02-09 2003-11-28 Univ Virginia Compostos derivados de felbamato
EP1196156B1 (en) * 1999-07-26 2008-04-30 SK Holdings Co., Ltd. Transnasal anticonvulsive compositions
DK1368021T3 (da) * 2001-02-27 2008-02-11 Ortho Mcneil Pharm Inc Carbamatforbindelser til anvendelse ved forebyggelse eller behandling af bipolær sygdom
NZ527988A (en) * 2001-02-27 2006-01-27 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating bipolar disorder
CN1235579C (zh) * 2001-02-27 2006-01-11 奥索-麦克尼尔药品公司 用于预防或治疗神经变性疾病的氨基甲酸酯化合物

Also Published As

Publication number Publication date
CO6382111A2 (es) 2012-02-15
NO20071921L (no) 2007-06-12
AU2005287174B2 (en) 2012-01-12
DE602005020667D1 (de) 2010-05-27
ATE464044T1 (de) 2010-04-15
MX2007003278A (es) 2007-10-08
ES2342185T3 (es) 2010-07-02
HRP20100304T1 (hr) 2010-09-30
JP2008513466A (ja) 2008-05-01
WO2006033947A3 (en) 2006-06-29
RS51269B (sr) 2010-12-31
AU2005287174A1 (en) 2006-03-30
CN101056629B (zh) 2012-01-11
IL181910A0 (en) 2007-07-04
CN101056629A (zh) 2007-10-17
CA2580640A1 (en) 2006-03-30
EA200700642A1 (ru) 2007-10-26
DK1809273T3 (da) 2010-08-02
KR20070057939A (ko) 2007-06-07
US20060194873A1 (en) 2006-08-31
NZ553813A (en) 2010-09-30
US20110152362A1 (en) 2011-06-23
WO2006033947A2 (en) 2006-03-30
PT1809273E (pt) 2010-05-10
BRPI0515374A (pt) 2008-07-22
HK1105583A1 (en) 2008-02-22

Similar Documents

Publication Publication Date Title
CR9053A (es) Uso de 2-fenil-1,2-etanodiol-(id) carbamatos para tratar epileptogenesis y epilepsia
WO2007008562A3 (en) Carbamate compounds for use in treating neurodegenerative disorders
TW200744575A (en) Methods of treating epileptogenesis
MY138156A (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders
YU67703A (sh) Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
DK1408953T3 (da) Carbamatforbindelser til anvendelse til forebyggelse eller behandling af bipolær sygdom
YU68003A (sh) Karbamatna jedinjenja za upotrebu u sprečavanju i lečenju bipolarnih poremećaja
RS67603A (en) Carbamate compounds for use in the treatment of pain
MX2009004553A (es) Metodos para el tratamiento de trastornos cocleares y vestibulares.
HK1062270A1 (en) Carbamate compounds for use in preventing or treating anxiety disorders
RS67503A (en) Carbamate compounds for use in preventing of treating psychotic disorders
TW200701978A (en) Methods of treating epileptogenesis and epilepsy
HK1063435A1 (en) Carbamate compounds for use in preventing or treating neuropathic pain
CY1110672T1 (el) Χρηση των 2- φαινυλ-1,2-αιθανοδιολης- (δι) καρβαμικων για θεραπεια επιληπτογενεσης
MY136733A (en) Carbamate compounds for use in preventing or treating psychotic disorders

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)